Zhuhai Rundu Pharmaceutical Co., Ltd.

The company is a modern technology-based pharmaceutical enterprise integrating drug research and development, production and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province, and was founded in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange. The company's main business is R&D, production and sales of chemical preparations, chemical raw materials, and pharmaceutical intermediates. The main products include rabeprazole sodium enteric capsules, irbesartan capsules, sartan raw materials and pharmaceutical intermediates. The product application range covers various drug fields such as peptic ulcers, high blood pressure, surgical local anesthesia, antipyretic analgesia, anti-infectious diseases, and diabetes. Corporate honors: National High-tech Enterprise; Guangdong Enterprise Technology Center; Guangdong Innovative Enterprise; National Torch Program Key High-tech Enterprise; Guangdong Engineering Technology Research Center; Guangdong Strategic Emerging Industry Cultivating Enterprise; National Postdoctoral Research Workstation; Guangdong Private Enterprise Innovation and Industrialization Demonstration Base; Passed the National Intellectual Property Management System certification. Some products have also received honorary titles such as the China Intellectual Property Excellence Award, Guangdong Famous High-tech Product, China Pharmaceutical's Leading Brand of the Year for High Quality Development, and Zhuhai Innovative Product.